Interní Med. 2015; 17(2): 61-62

Metabolic, or more precisely, cardiometabolic syndrome

prof.MUDr.Hana Rosolová, DrSc.

Centrum preventivní kardiologie &ndash, 2. interní klinika, LF UK a FN v Plzni

Summary: Metabolic or cardiometabolic syndrome (CMS) represents a complex of risk factors for cardiovascular atherosclerotic disease

and for type 2 diabetes mellitus. The last, s.c. „harmonized definition“ of CMS modified for the Czech population, is presented. Cardiometabolic

syndrome done by that definition is in association with 5times higher risk for type 2 diabetes and with 3times higher risk for

cardiovascular diseases than in subjects without CMS. To identify patients with CMS is important especially in primary prevention of

cardiovascular disease and diabetes. The background of this syndrome lies in insulin resistance and represents residual vascular risk,

which persists in up to date well-treated patients. This syndrome has become a symbol of the Czech Institute of Metabolic Syndrome

(CIMS, o. p. s.) non-profit organization, which was established in the year 2008. Some of CIMS activities are mentioned in the article.

Keywords: cardiometabolic syndrome, cardiovascular risk, type 2 diabetes mellitus, prevention, Czech Institute of Metabolic Syndrome

Published: April 10, 2015  Show citation